LTR Pharma Limited (ASX:LTP) Signs Collaborative Agreement for OROFLOW® Development
LTR Pharma (ASX:LTP) collaborates with SDS to develop OROFLOW®, a novel intranasal spray for Oesophageal Motility Disorders.
Tag: Corporate Strategy & Guidance
Geopacific Resources Limited (ASX:GPR) Unlocks New Porphyry Cu-Au Potential on Woodlark Island
Geopacific Resources (ASX:GPR) reveals 14 new porphyry Cu-Au targets at Woodlark Gold Project, boosting exploration prospects.
Credit Corp Group (ASX:CCP) Releases FY25 Market Update
Credit Corp Group (ASX:CCP) outlines its FY25 financial targets and strategic growth initiatives across US and Australian/NZ markets in its latest market update.
Spectur Limited (ASX:SP3) Appoints New CEO and Reports Strong Revenue Growth
Spectur Limited (ASX:SP3) appoints Anthony Schmidt as CEO and reports over $7M revenue for FY2023, highlighting strong growth and strategic expansion.
Brightstar Resources Limited (ASX:BTR) Announces Gold Drilling Results
Brightstar Resources (ASX:BTR) announces significant gold drilling results, advancing exploration and operational activities.
Swift Networks Group Ltd (ASX:SW1) Closes $3.3 Million Entitlement Offer
Swift Networks Group Ltd (ASX:SW1) closes $3.3M entitlement offer, raising $2.3M to fund product development and reduce debt.
Generation Development Group Limited (ASX:GDG) Forms Strategic Alliance with BlackRock
Generation Development Group Limited (ASX:GDG) partners with BlackRock to develop holistic retirement solutions for Australian retirees.
Algorae Pharmaceuticals (ASX:1AI) Partners with Peter MacCallum Cancer Centre for AI-Driven Drug Screening
Algorae Pharmaceuticals (ASX:1AI) partners with Peter MacCallum Cancer Centre to validate AI-driven drug synergies in oncology.
Pro Medicus Limited (ASX:PME) Signs A$20M Contract with University of Iowa Health Care
Pro Medicus Limited (ASX:PME) signs a A$20M, 5-year contract with University of Iowa Health Care for its cloud-based Visage 7 platform.
Helloworld Travel Limited (ASX:HLO) Updates FY25 Guidance and Reports Strong Operational Performance
Helloworld Travel (ASX:HLO) revises FY25 UEBITDA guidance due to market volatility, while reporting strong operational performance.